NAMSA and Advanced Medical Solutions Announce Preferred Partnership
NAMSA's testing, biological safety, regulatory and clinical research services will support the accelerated development and global market access of AMS's tissue-healing portfolio. TOLEDO, Ohio and WINSFORD, England, Nov. 9, 2026 /PRNewswire/ -- NAMSA, a world-leading MedTech Contract...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 106 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.